Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...

Oncology, titled "Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention," a research team from Guangzhou ...

More widespread use of mammograms, along with the implementation of targeted hormone therapies more than 40 years ago, has ...

and therapies that may help to reactivate its effect. There are two types of genes that are important in the development and growth of cancers: oncogenes and tumor-suppressor genes. Most often ...

But how do these cell therapies work? First, the researchers modify human cells by incorporating a network of genes that give the cells special abilities. These cells are implanted under the skin ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

The data, published in eLife, showcase the potential of NPRL2 as a single-agent therapy using the Oncoprex Delivery System. The Oncoprex system delivered the NPRL2 tumor suppressor gene via lipid ...

Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...

These findings provide evidence that promoter methylation of Dkk-3 is a common event in gastric cancer and that Dkk-3 is a tumor suppressor gene through the inhibition of Wnt signaling.

A new review published in Genes & Diseases explores the pivotal role of the ubiquitin-proteasome system (UPS) in regulating the tumor microenvironment (TME) and driving cancer progression. The study ...